Moderna (MRNA) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Moderna (MRNA) stock.

Latest Upgrades and Downgrades for Moderna Stock

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$137→$195
—	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$230→$305
—	William Blair	Myles Minter	Downgrade	Outperform→Market Perform	—
—	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$167→$230
—	TD Cowen	Tyler Van Buren	PT Raise	Hold	$40→$90
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$120→$137
—	Morgan Stanley	Terence Flynn	PT Raise	Equal-Weight	$89→$95
—	Citigroup	Geoff Meacham	Downgrade	Neutral→Sell	$60→$80
—	Rothschild & Co	Simon Baker	Downgrade	Neutral→Sell	$40→$81
—	Argus Research	John Eade	Upgrade	Hold→Buy	$180
—	Wolfe Research	Alexandria Hammond	Upgrade	Underperform→Peer Perform	—
—	Barclays	Eliana Merle	PT Raise	Equal-Weight	$48→$125
—	JP Morgan	Jessica Fye	PT Raise	Underweight	$40→$77
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$67→$120
—	UBS	Michael Yee	PT Raise	Neutral	$50→$150
—	Morgan Stanley	Terence Flynn	PT Raise	Equal-Weight	$39→$89
—	William Blair	Myles Minter	Upgrade	Market Perform→Outperform	—
—	Citigroup	Geoff Meacham	PT Raise	Neutral	$41→$60
—	Goldman Sachs	Salveen Richter	PT Raise	Neutral	$49→$67
—	Morgan Stanley	Matthew Harrison	PT Raise	Equal-Weight	$33→$39